Why not? Because the last thing NWBO shareholders can be accused of is not waiting and seeing long enough. And because at the rate NWBO does things it will be half a decade before we get additional data on Direct from trials that have not even started yet.
Should I wait for the data from the Phase 3 DCVax Prostate trial that has been pending partnership?
Market Data 
Markets 
AI
